ArticleThe Journal of antimicrobial chemotherapy2021

High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.

Emmanuel Ndashimye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.